« Prime-Boost HIV Vaccine Approach Shows Promise in Macaques; Janssen Aims to Advance to Human Efficacy Trials | Main | New Case of “Remission” Reported in a Perinatally Infected Teenager »


Chris Weston, Southern Illinois University

A great clinical trial would be to upregulate IL-21 in HIV patients while also using an HIV-Tat immunization. The clinical trials on HIV-Tat immunization were recently published (from Italy), and they showed significant increase in immune cells for up to two years, in comparison to a patient group only using HAART.

I think this is the next step in HIV therapy....perhaps a solution.

Verify your Comment

Previewing your Comment

This is only a preview. Your comment has not yet been posted.

Your comment could not be posted. Error type:
Your comment has been saved. Comments are moderated and will not appear until approved by the author. Post another comment

The letters and numbers you entered did not match the image. Please try again.

As a final step before posting your comment, enter the letters and numbers you see in the image below. This prevents automated programs from posting comments.

Having trouble reading this image? View an alternate.


Post a comment

Comments are moderated, and will not appear until the author has approved them.

Your Information

(Name and email address are required. Email address will not be displayed with the comment.)

Other Accounts

Search this blog

November 2023

Sun Mon Tue Wed Thu Fri Sat
      1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30    
Blog powered by Typepad
Member since 09/2005